Jaguar Health (JAGX) Work In Process (2018 - 2026)
Jaguar Health (JAGX) posted quarterly Work In Process of $6.9 million for Q1 2026, down 10.6% year-over-year from $7.7 million in Q1 2025, and down 4.56% quarter-over-quarter from $7.2 million in Q4 2025.
Jaguar Health (JAGX) Work In Process (2018 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Work In Process for 9 consecutive years, with $6.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Work In Process fell 10.6% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $6.9 million (down 10.6% YoY), while the FY2025 annual figure was $7.2 million, down 2.31% from the prior year.
- Work In Process retreated to $6.9 million in Q1 2026 per JAGX's latest filing, from $7.2 million in the prior quarter.
- Across five years, Work In Process topped out at $7.7 million in Q1 2025 and bottomed at $2.4 million in Q1 2022.
- Historically, Work In Process has averaged $5.8 million across 5 years, with a median of $6.5 million in 2023.
- Annual changes were most pronounced in 2023 — Work In Process jumped 122.25% — and 2026, when it decreased 10.6%.
- Jaguar Health's Work In Process stood at $3.6 million in 2022, then soared by 81.08% to $6.5 million in 2023, then increased by 13.66% to $7.4 million in 2024, then retreated by 2.31% to $7.2 million in 2025, then dropped by 4.56% to $6.9 million in 2026.
- Business Quant data shows JAGX's Work In Process at $6.9 million in Q1 2026, $7.2 million in Q4 2025, and $7.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.41 Bn | 130.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.41 Bn | 59.23 Bn | 1.37 Bn |
| 4 | Moderna | 57.56 Bn | 52.43 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.06 Bn | 36.96 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.95 Bn | 27.65 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.48 Bn | 9.09 Bn | 668.28 Mn |
| 8 | Insmed | 27.31 Bn | 26.15 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.04 Bn | 26.20 Bn | - |
| 10 | Jaguar Health | 459,051.31 | -9.60 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.91 Mn |
| Dec 31, 2025 | 7.24 Mn |
| Sep 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.61 Mn |
| Mar 31, 2025 | 7.73 Mn |
| Dec 31, 2024 | 7.41 Mn |
| Sep 30, 2024 | 7.01 Mn |
| Jun 30, 2024 | 6.83 Mn |
| Mar 31, 2024 | 6.13 Mn |
| Dec 31, 2023 | 6.52 Mn |
| Sep 30, 2023 | 5.72 Mn |
| Jun 30, 2023 | 5.40 Mn |
| Mar 31, 2023 | 5.38 Mn |
| Dec 31, 2022 | 3.60 Mn |
| Sep 30, 2022 | 3.06 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 2.76 Mn |
| Sep 30, 2021 | 2.20 Mn |
| Jun 30, 2021 | 1.71 Mn |